SEC Form 4 · accession 0001179110-18-006356
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J Coughlin
Director
Period of report
Feb 28, 2018
Accepted (ET)
May 4, 2018 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F3 | Feb 28, 2018 | G | 10,000 | $0.00 | D | 4,446 | D | |
| Ordinary Shares, par value $0.0001F2,F3 | May 2, 2018 | A | 1,985 | $151.07 | A | 6,431 | D | |
| Oridnary Shares, par value $0.0001 | holding | — | — | — | 10,000 | I | By grantor retained annuity trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects a transfer to a grantor retained annuity trust for which the reporting person is the trustee and sole annuitant.
- F2These restricted stock units shall vest 100% on the earlier of (i) the day before the 2019 Annual General Meeting of Shareholders and (ii) May 2, 2019.
- F3Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney